awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35906490-6C93DE2D-144C-46A3-848F-7F187D5A3785
Q35906490-6C93DE2D-144C-46A3-848F-7F187D5A3785
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35906490-6C93DE2D-144C-46A3-848F-7F187D5A3785
SGLT-2 Inhibitors: A New Mechanism for Glycemic Control.
P2860
Q35906490-6C93DE2D-144C-46A3-848F-7F187D5A3785
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35906490-6C93DE2D-144C-46A3-848F-7F187D5A3785
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1831fcf81f3c1e217fd2deabd1c3f0384f1bc54f
P2860
Dose-ranging effects of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to metformin in subjects with type 2 diabetes.